What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?

다국어 초록 (Multilingual Abstract)

Objective: To retrospectively assess conventional magnetic resonance imaging (MRI) features that differentiate malignant pure mesenchymal uterine tumors (MPMUT); endometrial stromal sarcoma (ESS) and leiomyosarcoma (LMS) from uterine leiomyoma with cystic degeneration (ULCD).
Methods: We retrospectively reviewed magnetic resonance (MR) images of 30 patients with ULCD, 18 with ESS, and 15 with LMS, to assess tumor location, margin, T2 signal intensity (SI), speckled appearance, and peripheral band using univariate and multivariate analyses.
Results: ULCD more frequently showed subserosal location (53.3%), well-defined margin (96.7%), and speckled appearance (90.0%) compared with ESS (0%, 33.3%, and 33.3%, respectively) or LMS (20.0%, 33.3%, and 60.0%, respectively). In quantitative T2 SI comparisons, the T2 SI ratio of the main solid tumor portion to gluteus maximus muscle differed significantly among the three groups, with ULCD showing a lower SI ratio (0.62) compared with ESS (2.44) and LMS (1.13). On multivariate analysis, an ill-defined margin (odds ratio [OR]=44.885; p=0.003) and high T2 SI (OR=4.396; p=0.046) were the significant MR differentiators.
Conclusion: An ill-defined tumor margin and high T2 SI ratio of the main solid tumor-to-gluteus maximus muscle were useful MRI features in the differentiation of MPMUT from ULCD.

참고문헌 (Reference)

1 Santos P, "Uterine sarcomas: clinical presentation and MRI features" 21 : 4-9, 2015

2 D’Angelo E, "Uterine sarcomas: a review" 116 : 131-139, 2010

3 Wright JD, "Uterine pathology in women undergoing minimally invasive hysterectomy using morcellation" 312 : 1253-1255, 2014

4 Murase E, "Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment" 19 : 1179-1197, 1999

5 Ueda H, "Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds" 19 : S131-S145, 1999

6 US Food and Drug Administration, "UPDATED Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication"

7 Tanaka YO, "Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings" 20 : 998-1007, 2004

8 Schlaerth AC, "Role of minimally invasive surgery in gynecologic cancers" 11 : 895-901, 2006

9 Hagemann IS, "Risk of occult malignancy in morcellated hysterectomy: a case series" 30 : 476-483, 2011

10 Creasman W, "Revised FIGO staging for carcinoma of the endometrium" 105 : 109-, 2009

11 Wilde S, "Radiological appearances of uterine fibroids" 19 : 222-231, 2009

12 Senapati S, "Power morcellators: a review of current practice and assessment of risk" 212 : 18-23, 2015

13 Picerno TM, "Morcellation and the incidence of occult uterine malignancy: a dual-institution review" 26 : 149-155, 2016

14 Zhang GF, "Magnetic resonance and diffusion-weighted imaging in categorization of uterine sarcomas: correlation with pathological findings" 38 : 836-844, 2014

15 Cornfeld D, "MRI appearance of mesenchymal tumors of the uterus" 74 : 241-249, 2010

16 Koyama T, "MR imaging of endometrial stromal sarcoma: correlation with pathologic findings" 173 : 767-772, 1999

17 Ha HK, "MR imaging analysis of heterogeneous leiomyomas of the uterus" 2 : f4-f12, 1997

18 US Food and Drug Administration, "Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication"

19 Thomassin-Naggara I, "How to differentiate benign from malignant myometrial tumours using MR imaging" 23 : 2306-2314, 2013

20 Prat J, "FIGO staging for uterine sarcomas" 104 : 177-178, 2009

21 Furukawa R, "Endometrial stromal sarcoma located in the myometrium with a low-intensity rim on T2-weighted images: report of three cases and literature review" 31 : 975-979, 2010

22 Amant F, "Endometrial cancer" 366 : 491-505, 2005

23 Steiner RA, "Electrical cutting device for laparoscopic removal of tissue from the abdominal cavity" 81 : 471-474, 1993

24 Cagnacci A, "Early outcome of myomectomy by laparotomy, minilaparotomy and laparoscopically assisted minilaparotomy. A randomized prospective study" 18 : 2590-2594, 2003

25 Schwartz LB, "Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata?" 70 : 580-587, 1998

26 Vitiello D, "Diagnostic imaging of myomas" 33 : 85-95, 2006

27 Namimoto T, "Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas" 19 : 2756-2764, 2009

28 Amant F, "Clinical management of uterine sarcomas" 10 : 1188-1198, 2009

29 Zhang J, "Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy" 130 : 195-199, 2015

30 Chaudhry S, "Benign and malignant diseases of the endometrium" 14 : 339-357, 2003

31 Sumi A, "Assessment of MR imaging as a tool to differentiate between the major histological types of uterine sarcomas" 14 : 295-304, 2015